Core Points - Churchill Capital Corp VII and CorpAcq Holdings Limited have mutually agreed to terminate their merger agreement due to unfavorable IPO market conditions [1][2] - Churchill will not complete an initial business combination by the deadline of August 17, 2024, and intends to dissolve and liquidate its trust account proceeds [3][4] - The per-share redemption price for public shares will be approximately $10.84, with the last trading day on Nasdaq being August 16, 2024 [5][6] Company Information - Churchill Capital Corp VII is a publicly-traded special purpose acquisition company formed to effect a merger or similar business combination [8] - CorpAcq Holdings Limited is a corporate compounder with a diversified portfolio of 43 companies as of May 1, 2024, focusing on acquiring and supporting founder-led businesses [9]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40051 | --- | --- | --- | |----------------------------------------------------------------------------------------------- ...

Stockholders may elect to redeem shares of Class A Common Stock until 5:00 pm Eastern Time, August 9, 2024 NEW YORK, Aug. 5, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that the deadline for Churchill VII stockholders to elect redemption of their shares of class A common stock of Churchill VII ("Class A Common Stock") in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), ...

Expected Financing Would De-Risk Closing of Business Combination and is Anticipated to Support CorpAcq's Future Growth NEW YORK and ALTRINCHAM, England, Aug. 2, 2024 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill Capital Corp VII ("Churchill VII") (NASDAQ: CVII), a special purpose acquisition company, today provided an update on planned equity or equity-linked financing in support of th ...

Call scheduled for 11am ET on Monday, July 29, 2024 ALTRINCHAM, England and NEW YORK, July 29, 2024 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII) today announced that CorpAcq will host a webcast and conference call to provide a business update at 11 AM ET on Monday, July 29, 2024. As announced on August 1, 2023, Churchill entered into a ...

Churchill VII stockholders and public warrant holders of record as of the close of business on June 18, 2024 (the "Record Date") will receive the definitive proxy statement/prospectus, once available (the "Proxy Statement") relating to the offer of the securities to be issued by CorpAcq Group Plc to Churchill VII's stockholders and public warrant holders in connection with the completion of the Business Combination by mail and are entitled to vote at the Stockholder Special Meeting and/or Warrant Holder Mee ...

UNITED STATES Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapte ...

● our ability to select an appropriate target business or businesses; ● our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; 18 ● provisions in our amended and restated certificate of incorporation and Delaware law that may have the effect of inhibiting a takeover of us and discouraging lawsuits against our directors and officers, and limiting our stockholders' ability to obtain a ...

Board of Directors Recommends Stockholders and Warrant Holders Vote "FOR" All ProposalsNEW YORK and ALTRINCHAM, England, March 22, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders and a meeting of Churchill VII warrant holders for May 21, 2024 in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), a corporate ...

In Excess of $605 Million Remains in Churchill VII's Trust Account after Stockholder Redemptions relating to the Extension NEW YORK, Feb. 12, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NASDAQ: CVII) announced today that in a special meeting of its stockholders ("Special Meeting"), Churchill VII's stockholders voted to approve a proposal to amend Churchill VII's certificate of incorporation and extend the date by which Churchill VII is required to consummate its initial business combi ...